Serial Number | 79357367 |
Word Mark | SATIVEX |
Filing Date | Wednesday, November 16, 2022 |
Status | 641 - NON-FINAL ACTION - MAILED |
Status Date | Friday, April 26, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | NOT AVAILABLE |
Goods and Services | Pharmaceutical and veterinary preparations for use in treating pain, neuropathic pain, cancer pain, multiple sclerosis, spinal cord injury, bladder dysfunction, peripheral neuropathy, spasticity, cancer and cancer symptoms, perioperative pain, rheumatoid arthritis, inflammatory bowel disease, ulcerative colitis, hypoxic-ischaemic encephalopathy, symptoms of neurogenic disorders, movement disorders, essential tremors, psychotic disorders, diseases of the central nervous system, stroke and head injuries, motion sickness and chemically induced sickness, spasticity, psychiatric illnesses, post-traumatic stress disorder, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with Type II Diabetes, bulimia, schizophrenia, Crohn's disease, Alzheimer's disease, bone disorders, inflammatory disorders, sleep and sleep disorders, and drug, alcohol, and nicotine abuse; herbs for medicinal purposes; medicinal herbs; medicinal oils; medicinal infusions for use in treating pain, neuropathic pain, cancer pain, multiple sclerosis, spinal cord injury, bladder dysfunction, peripheral neuropathy, spasticity, cancer and cancer symptoms, perioperative pain, rheumatoid arthritis, inflammatory bowel disease, ulcerative colitis, hypoxic-ischaemic encephalopathy, symptoms of neurogenic disorders, movement disorders, essential tremors, psychotic disorders, diseases of the central nervous system, stroke and head injuries, motion sickness and chemically induced sickness, spasticity, psychiatric illnesses, post-traumatic stress disorder, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with Type II Diabetes, bulimia, schizophrenia, Crohn's disease, Alzheimer's disease, bone disorders, inflammatory disorders, sleep and sleep disorders, and drug, alcohol, and nicotine abuse; pure extracts of medicinal plants and herbs; foodstuffs for medicinal purposes, namely, dietetic foods adapted for medical use; herb teas for medicinal purposes |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Monday, December 12, 2022 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | GW Research Limited |
Party Type | 11 - New Owner Before Publication |
Legal Entity Type | 98 - Unknown |
Address | GB |
Party Name | GW Pharma Limited |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | GB |
Event Date | Event Description |
Thursday, December 8, 2022 | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB |
Monday, December 12, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Friday, December 16, 2022 | APPLICATION FILING RECEIPT MAILED |
Thursday, January 5, 2023 | INTERNATIONAL REGISTRATION RENEWED |
Wednesday, August 30, 2023 | ASSIGNED TO EXAMINER |
Thursday, September 7, 2023 | NON-FINAL ACTION WRITTEN |
Friday, September 8, 2023 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
Tuesday, September 26, 2023 | REFUSAL PROCESSED BY MPU |
Tuesday, September 26, 2023 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
Monday, October 16, 2023 | REFUSAL PROCESSED BY IB |
Tuesday, March 26, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Tuesday, March 26, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Tuesday, March 26, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Friday, April 26, 2024 | NON-FINAL ACTION WRITTEN |
Friday, April 26, 2024 | NON-FINAL ACTION E-MAILED |
Friday, April 26, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Wednesday, May 8, 2024 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
Wednesday, May 8, 2024 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
Friday, May 31, 2024 | CHANGE OF OWNER RECEIVED FROM IB |
Sunday, June 2, 2024 | REFUSAL PROCESSED BY IB |
Tuesday, June 11, 2024 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |